Literature DB >> 7271878

Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.

M Inaba, R Fujikura, Y Sakurai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7271878     DOI: 10.1016/0006-2952(81)90027-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line.

Authors:  A M Van der Bliek; T Van der Velde-Koerts; V Ling; P Borst
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

3.  Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.

Authors:  S I Hsu; D Cohen; L S Kirschner; L Lothstein; M Hartstein; S B Horwitz
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  The in-vitro chemosensitivity of three cell lines derived from the VM/DK spontaneous murine astrocytoma.

Authors:  R Bradford; J L Darling; D G Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

5.  Cells resistant to cytotoxic drugs are recognized by monoclonal antibody.

Authors:  C J O'Hara; J Grover; G B Price
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

6.  Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines.

Authors:  M H de Bruijn; A M Van der Bliek; J L Biedler; P Borst
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients.

Authors:  M Beksac; C Peterson; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Cytofluorescence localization of adriamycin in resistant colon cancer cells.

Authors:  B Chauffert; F Martin; A Caignard; J F Jeannin; A Leclerc
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.

Authors:  B T Hill; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

10.  Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.

Authors:  H Shinoda; H Ebisu; J Mitsuhashi; M Inaba; T Tsuruo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.